CBIZ 13G/A: Capital Research Reports 0 Shares
CBIZ, Inc. Schedule 13G/A amendment: Capital Research Global Investors filed Amendment No. 2 reporting beneficial ownership of 0 shares, or 0.0%, of CBIZ's common stock, out of 50,073,624 shares believed to be outstanding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CBIZ, Inc. Schedule 13G/A amendment: Capital Research Global Investors filed Amendment No. 2 reporting beneficial ownership of 0 shares, or 0.0%, of CBIZ's common stock, out of 50,073,624 shares believed to be outstanding. The filing is signed by a CRMC officer.
Insights
Passive holder reports zero ownership; no voting or disposition powers disclosed.
The filing states Capital Research Global Investors is deemed beneficial owner of 0 shares and reports 0 in all voting and dispositive power fields. The filing cites an estimated 50,073,624 shares believed outstanding.
These amendments typically update ownership records; cash‑flow treatment and timing are not stated in the excerpt. Subsequent filings would show any material ownership changes.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficial ownership financial
CUSIP regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does CBZ Schedule 13G/A Amendment No. 2 report?
Who signed the Amendment No. 2 for CBZ and what is their role?
AI-generated analysis. How Rhea-AI works. Not financial advice.